E. Bel (Leiden, The Netherlands), D. Kirsten (Grosshansdorf, Germany)
Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma
H. Fox, K. Surrey, S. Hedgecock, C. Reisner (Horsham, United Kingdom; East Hanover, United States Of America)
|   |
Asthma patients adjust their maintenance treatment late in response to worsening asthma symptoms
T. van der Molen, M. R. Partridge, S. E. Myrseth, W. Busse (Groningen, Netherlands; London, United Kingdom; Brussels, Belgium; Madison, United States Of America)
| |
Empirical evidence supporting the ACT score to identify/monitor patients with poorly controlled asthma
M. Schatz, C. Sorkness, M. Kosinski, J. Li, P. Marcus, J. Murray, R. Nathan, P. Jhingran (San Diego, Madison, Lincoln, Rochester, Great Neck, Nashville, Colorado Springs, Research Triangle Park, United States Of America)
| |
Asthma admissions to ITU: 5 year audit of admissions in a secondary care setting
B. Gooptu, V. Tse, M. Monaghan, S. Ahmed, K. Ganeslingam (Southend, London, United Kingdom)
| |
Fatal asthma in Sweden
S. E. Bergström, G. Boman, L. Eriksson, H. Formgren, T. Foucard, G. Hedlin, L. G. Hörte, U. Spetz-Nyström (Stockholm, Uppsala, Sweden)
| |
Severe asthma, panic disorder and depression
A. Potoczek, E. Nizankowska, G. Bochenek (Cracow, Poland)
| |
"It‘s like living with a time bomb"– European patients‘ perspective on severe asthma symptoms
M. J. Dockrell, K. Webb, S. E. Myrseth, J. Olsen, C. Rolland, C. Chaine (Stockholm, Sweden; Paris, France)
| |
Conclusion: clinical phenotypes of asthma
E. Bel (Leiden, Netherlands)
| |